Japan, Jan. 28 -- ATYR PHARMA INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR TREATING NRP2-ASSOCIATED DISEASES.' Other related details are as follows:
Application Number: JP,2024-051195
Category (FI): A61K35/17,A61K35/768,A61K38/19,A61K38/20,A61K38/21,A61K38/22,A61K38/30,A61K38/43,A61K39/00@H,A61K39/395@U,A61K40/11,A61K40/31,A61K40/32,A61K45/00,A61K47/68,A61P11/00,A61P11/06,A61P15/00,A61P17/00,A61P17/02,A61P19/00,A61P19/02,A61P25/00,A61P27/00,A61P27/04,A61P29/00,A61P29/00,101,A61P31/00,A61P31/04,A61P31/10,A61P33/02,A61P35/00,A61P35/04,A61P37/06,A61P37/08,A61P43/00,111,A61P43/00,121,A61P7/00,A61P7/10,A61P9/00,C07K14/02,C07K14/025,C07K14/49,C07K14/495,C07K14/50,C07K14/535,C07K14/55,C07K14/56,C07K14/62,C07K14/705,...